US Pre-Market SEC Filings Roundup — September 25, 2026

24-09-2026

VP, Finance & CAO Borges David J. sold 10,000 Common Stock at $20.95 (~$210K). 8 transactions reported in total. Borges David J. holds 10,000 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · VP, Finance & CAO Borges David J. exercised/converted 5,000 Common Stock at $3.93 (~$19.7K)
• · VP, Finance & CAO Borges David J. exercised/converted 5,000 Common Stock at $2.94 (~$14.7K)
• · VP, Finance & CAO Borges David J. sold 10,000 Common Stock at $20.95 (~$210K)
• · VP, Finance & CAO Borges David J. exercised/converted 10,000 Common Stock at $15.58 (~$156K)
• · VP, Finance & CAO Borges David J. sold 10,000 Common Stock at $20.95 (~$210K)
• · VP, Finance & CAO Borges David J. exercised/converted 5,000 Stock Option (Right to Buy)
• · VP, Finance & CAO Borges David J. exercised/converted 5,000 Stock Option (Right to Buy)
• · VP, Finance & CAO Borges David J. exercised/converted 10,000 Stock Option (Right to Buy)

24-09-2026

Wood River Capital, LLC sold 12,280,426 Common Stock at $4.73 (~$58.1M).

• · Wood River Capital, LLC sold 12,280,426 Common Stock at $4.73 (~$58.1M)

24-09-2026

Director SEBULSKY ALAN was awarded 100,000 Restricted Share Units.

• · Director SEBULSKY ALAN was awarded 100,000 Restricted Share Units

24-09-2026

Director Lee Kang Jyh sold 10,000 COMMON STOCK at $29.70 (~$297K). Lee Kang Jyh holds 354,850 shares after the transaction.

• · Director Lee Kang Jyh sold 10,000 COMMON STOCK at $29.70 (~$297K)

24-09-2026

Director Slingsby Brian Taylor sold 104,320 Common Stock at $28.81 (~$3.01M). Slingsby Brian Taylor holds 7,805,718 shares after the transaction.

• · Director Slingsby Brian Taylor sold 104,320 Common Stock at $28.81 (~$3.01M)

24-09-2026

NextEra Energy, Inc. is pursuing a pending business combination with Dominion Energy, Inc., as disclosed in a Rule 425 filing on September 24, 2026. The transaction is subject to regulatory approvals and other closing conditions, with a registration statement (Form S-4) already declared effective by the SEC on July 23, 2026. No specific financial terms or performance metrics are provided in this communication.

• · The filing is a communication under Rule 425 of the Securities Act of 1933.
• · The related registration statement on Form S-4 (No. 333-297351) was filed on July 9, 2026, and declared effective on July 23, 2026.
• · The definitive joint proxy statement/prospectus was filed on July 28, 2026.
• · The communication includes forward-looking statements with numerous risk factors, including integration challenges, regulatory approvals, and market conditions.
• · No financial terms, deal value, or transaction structure are disclosed in this filing.

24-09-2026

NuCube Energy, Inc. issued social media posts on September 24, 2026, highlighting its use of AI-aided optimization in its proprietary Fuel Moderator and Absorber assembly technology for advanced nuclear reactor design. The posts are part of ongoing communications related to the proposed business combination with Launch Two Acquisition Corp., which filed a Form S-4 on September 11, 2026. No financial metrics or performance data were disclosed.

• · The Form S-4 was filed on September 11, 2026, with Launch Two as the subject company and NuCube as co-registrant.
• · The social media posts were made on LinkedIn and X on September 24, 2026.
• · The technology uses AI-aided core-loading optimization to improve fuel utilization, support longer core life, simplify safety requirements, and reduce long-lived waste.

25-09-2026

Tamboran Resources Corp reported first gas sales to the Northern Territory gas market in September 2026, a key milestone. The company completed the largest stimulation campaign in the Beetaloo Basin (178 stages) and delivered the SPCF construction ~US$9 million under budget. However, the pro forma cash balance of ~US$240 million is down from the US$300 million raised earlier, and the company carries US$30 million in debt, with near-term inflows of only US$15 million pending conditions.

• · Tamboran is the fourth largest listed-Australian E&P by market capitalization (A$1,928 million).
• · Implied acreage value is US$377 per acre.
• · The company has 3-4 stacked benches across two key depocenters.
• · First gas sales commenced in September 2026 under interruptible supply terms at 75% of gas price.
• · Take-or-pay provisions will apply to the 40 TJ/d contract quantity upon commencement of the supply period.
• · A non-binding MOU with Liberty Energy sets out intent to extend the hydraulic fracture stimulation and wireline services agreement.
• · The acreage sale to DWE (US$15 million) is subject to conditions precedent including DWE obtaining approval from the Formentera Australia Fund, LP’s Limited Partner Advisory Committee.
• · Working interests are subject to completion of minority shareholder compulsory acquisition of Falcon Oil & Gas Australia Limited.

25-09-2026

Addex Therapeutics Ltd filed a Form 6-K with the SEC on September 25, 2026, attaching a press release of the same date. The filing incorporates the press release by reference into its existing registration statements. The company cautions that its business faces significant risks and that forward-looking statements involve uncertainties that could cause actual results to differ materially.

• · The press release is incorporated by reference into Form F-3 (Registration No. 333-291644) and Form S-8 (Registration No. 333-255124 and No. 333-272515).
• · The company's Annual Report on Form 20-F for the year ended December 31, 2025 was filed on May 15, 2026.
• · Risk factors from the Annual Report and other SEC filings are referenced as potentially materially affecting the business.

25-09-2026

AngloGold Ashanti hosted a site visit for institutional investors and analysts at its consolidated Beatty Mining District in Nevada, providing an update on progress toward developing the newest major gold-producing district in the US. The district is anchored by the North Bullfrog Project and the Tier-One Arthur Gold Project. The filing is a routine investor relations update with no financial figures or performance data disclosed.

• · The site visit was held on September 25, 2026, for institutional investors and analysts.
• · The presentation pack is available for download on the AngloGold Ashanti website.
• · The Arthur Gold Project is described as a Tier-One asset, defined as a large, long-life, low-cost operation in a stable jurisdiction.

25-09-2026

Alterity Therapeutics Ltd filed a Form 6-K with the SEC on September 25, 2026, announcing the date of its Annual General Meeting (AGM) and the closing date for director nominations. The filing also incorporates the report by reference into the company's existing registration statements on Form S-8 and Form F-3. No financial results or operational updates were provided in this filing.

• · The filing is incorporated by reference into Registration Statements on Form S-8 (File Nos. 333-251073, 333-248980, 333-228671) and Form F-3 (File No. 333-274816).
• · The company is described as a development stage enterprise.
• · The AGM date and director nomination closing date are provided in Exhibit 99.1, which is not included in the filing text.

25-09-2026

Yip Wai Lun filed a Schedule 13G with the SEC on September 25, 2026, disclosing beneficial ownership of 208,334 shares of Addentax Group Corp. common stock, representing 9.90% of the 2,105,058 shares outstanding as of September 22, 2026. The filing indicates the shares were acquired in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

• · The filing is made under Rule 13d-1(c), indicating the filer is a passive investor.
• · Yip Wai Lun has sole voting and dispositive power over all 208,334 shares.
• · The filing date is September 25, 2026, with the event date of September 22, 2026.

25-09-2026

Non Invasive Monitoring Systems Inc (NIMU) filed an amended S-4 registration statement related to its proposed merger with Gravitics Inc, a space infrastructure company. The filing includes financial statements for both entities and details of the merger agreement. While the merger represents a strategic pivot into the space sector, the company continues to report significant accumulated deficits and relies on related-party financing, indicating ongoing financial challenges.

• · The S-4/A filing is an amendment to the registration statement for the merger with Gravitics Inc.
• · The merger agreement was dated March 6, 2026, with a subsequent event on August 5, 2026.
• · The filing includes financial data for the six months ended June 30, 2026, and the fiscal year ended July 31, 2025.
• · Related-party promissory notes from Frost Gamma Investments Trust and Dr. Jane Hsiao are disclosed, indicating ongoing related-party financing.
• · The company has a history of accumulated deficits, as evidenced by retained earnings data across multiple periods.
• · The filing references a convertible promissory note purchase agreement dated June 24, 2026.

25-09-2026

Everli Global Inc. and Melar Acquisition Corp. I filed an amended S-4 registration statement for their proposed business combination, which includes a merger consideration of $180 million plus up to $30 million in PIPE financing and a $10 million bridge financing facility. The bridge financing has been partially satisfied through a $3,611,111 promissory note and a $7,500,000 convertible note, both with a 10% original issue discount. The transaction is subject to shareholder approval at an extraordinary general meeting, and the merger consideration shares are valued at $10.00 per share.

• · The Merger Agreement was dated July 30, 2025, and amended on October 2, 2025 and December 8, 2025.
• · The merger consideration shares are divided into Class A (1 vote per share) and Class B (30 votes per share) common stock.
• · The bridge financing includes a $3,611,111 promissory note and a $7,500,000 convertible note, both with a 10% OID.
• · The escrow period for merger consideration shares is 24 months from the closing date.
• · The filing is a preliminary proxy statement/prospectus subject to completion, dated September 24, 2026.

25-09-2026

Mobile-health Network Solutions (MNDR) issued 1,980,000 Class A and 500,000 Class C ordinary shares to 6 directors and officers as part of their FY2027 remuneration, approved by the Board on September 22, 2026. The shares are subject to transfer restrictions under a deed of undertaking. No financial impact or performance metrics were disclosed in this filing.

• · Board approval date: September 22, 2026
• · Filing date: September 25, 2026; signed September 24, 2026
• · Shares are part of fiscal year 2027 remuneration packages
• · Shares subject to transfer restrictions per deed of undertaking

25-09-2026

Atomic Invest LLC filed a Form 13F-HR on September 25, 2026, reporting 356 holdings as of March 31, 2026. The portfolio included broad exposure to equities, ETFs, bonds, commodities, and digital-asset products, with notable reported positions in Fidelity Wise Origin Bitcoin Fund, iShares Ethereum Trust, Bit Digital, Inc., and large-cap technology companies; the filing provides no prior-period data for comparison.

• · The period of report was March 31, 2026.
• · The filing was signed on September 24, 2026, and filed on September 25, 2026.
• · The reported holdings included 231455 shares of Fidelity Wise Origin Bitcoin Fund, 288754 shares of iShares Ethereum Trust, and 173165 shares of iShares Bitcoin Trust.
• · The portfolio contained diversified exposure to equities, fixed income, real estate, commodities, gold, silver, and cryptocurrency-related products.
• · All listed positions were reported as held solely, with no shared or non-shared voting authority shown for the reported holdings except where specified in the information table.

25-09-2026

Box Inc. filed an 8-K on September 25, 2026, regarding the departure or election of a director or officer (Item 5.02). The filing incorporates by reference details about Mr. Smith from the company's Proxy Statement filed on May 13, 2026. No specific financial figures or performance metrics were disclosed in this filing.

• · The filing relates to Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers).
• · Details about Mr. Smith are incorporated by reference from the Proxy Statement filed on May 13, 2026.

25-09-2026

Jupiter Neurosciences filed an S-3 registration statement to register up to 132,867 shares of common stock for resale by selling stockholder PharmAla. The company will not receive any proceeds from the sale. The filing highlights severe financial distress: the company has limited cash, a going concern opinion from its auditor, and faces Nasdaq delisting due to failure to meet the minimum market value of listed securities requirement, despite having regained compliance with the minimum bid price requirement after a 1-for-75 reverse stock split.

• · The company received a delisting determination from Nasdaq on August 27, 2026 for failure to meet the minimum market value of listed securities requirement.
• · The company has appealed the delisting determination and requested a hearing before the Nasdaq Hearings Panel, which is expected to stay delisting pending the Panel's decision.
• · Management has concluded that historical recurring losses and negative cash flows raise substantial doubt about the company's ability to continue as a going concern.
• · The company's auditor included a going concern explanatory paragraph in its audit reports for fiscal years ended December 31, 2025 and 2024.
• · The company regained compliance with the minimum bid price requirement on August 27, 2026 after a 1-for-75 reverse stock split.
• · The company believes it has stockholders' equity in excess of $2.5 million following an August 2026 registered direct offering and is awaiting Nasdaq's formal determination.

25-09-2026

News Corp filed an 8-K on September 25, 2026, disclosing daily repurchase transaction information provided to the Australian Securities Exchange (ASX) under its existing $1 billion stock repurchase program. The filing reiterates the company's authorization to buy back up to $1 billion in aggregate of its Class A and Class B common stock, but does not report any specific new buyback activity or financial results for the period.

• · The filing is a routine disclosure of information provided to the ASX regarding the repurchase program, not a new authorization or update on actual repurchase volumes.
• · The company disclaims any obligation to update forward-looking statements except as required by law.

25-09-2026

Dolphin Entertainment, Inc. filed a DEFA14A (definitive additional proxy materials) with the SEC on September 25, 2026, providing supplemental information for its upcoming shareholder meeting. The filing includes a graphic image but no new financial data or material corporate developments. The document is purely procedural, updating or clarifying proxy solicitation materials.

25-09-2026

YYForce Inc. (formerly YY Group Holding Limited) filed a Form 6-K on September 25, 2026, reporting its unaudited interim financial results for the six months ended June 30, 2026. The filing includes condensed consolidated financial statements, management's discussion and analysis, and a press release. No specific financial figures or period-over-period comparisons are provided in the filing itself, only the fact that results were reported.

• · The company changed its name from YY Group Holding Limited to YYForce Inc.
• · The filing is for the six months ended June 30, 2026, with comparative figures for the six months ended June 30, 2025.
• · The report is incorporated by reference into the company's registration statements on Form F-3 (File No. 333-286705 and 333-297406).

25-09-2026

On September 24, 2026, PLAYSTUDIOS, Inc. filed an 8-K to announce the effective date and split ratio of its previously announced reverse stock split. The company issued a press release (Exhibit 99.1) detailing the terms, but the filing does not disclose the specific split ratio or effective date. This corporate action is typically taken to meet Nasdaq listing requirements or boost the stock price, which may signal underlying financial or compliance challenges.

• · The reverse stock split was previously announced, and this filing provides the effective date and split ratio.
• · The specific split ratio and effective date are not included in the 8-K text; they are referenced only in the attached press release (Exhibit 99.1).
• · The filing is furnished under Item 8.01 (Other Events) and is not deemed filed for Section 18 liability purposes.

25-09-2026

Quanome Technologies, Inc. (Nasdaq: QNME) filed an amendment to its Form 8-K to correct its principal executive office address and telephone number from its former Illinois location to its current New York address. The amendment also furnished a press release announcing an approximately $18.8 million purchase agreement for NVIDIA GPU-based computing infrastructure to advance its AI cloud business through subsidiary XDT Infrastructure I, LLC, with the first U.S. hub expected to be operational from Q4 2026. The filing is a procedural correction and forward-looking business update with no financial results or period-over-period comparisons.

• · The company changed its name from Lakeside Holding Ltd to Quanome Technologies, Inc. on October 4, 2023.
• · The original Form 8-K was filed on September 23, 2026, and inadvertently included the former Illinois office address and prior telephone number.
• · The press release was issued on September 23, 2026.
• · The purchase agreement was entered into on September 16, 2026.
• · The company is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.
• · The company's common stock trades under the symbol QNME on Nasdaq.
• · The company's fiscal year ends on June 30.
• · The U.S. Census Bureau reported that 17% to 20% of U.S. businesses used AI between December 2025 and May 2026, and 20% to 23% expected to use it in the following six months.

25-09-2026

NexPoint Capital, Inc. disclosed in an 8-K filing that as of September 22, 2026, its net asset value per share (NAV) was determined to be $4.64. This NAV also serves as the price for shares issued under the company's distribution reinvestment plan (DRP). The valuation was performed by the investment adviser in accordance with established policies and approved by the Board under Rule 2a-5 of the Investment Company Act.

• · The DRP share price is set by the investment adviser in its sole discretion and must not be less than the NAV per share determined immediately prior to the distribution payment.
• · The valuation was performed under Rule 2a-5 of the Investment Company Act of 1940.

25-09-2026

Interpace Biosciences, Inc. filed an S-1 registration statement with the SEC on September 24, 2026, for a proposed public offering of its common stock. The company, which provides molecular diagnostic tests for cancer risk assessment, is currently focused on its thyroid cancer tests (ThyGeNEXT® and ThyraMIR®v2) after losing Medicare reimbursement for its pancreatic cancer test (PancraGEN®) in April 2025, leading to discontinuation of that test in May 2025. While the global molecular diagnostics market is projected to grow at an 11.1% CAGR to $75.9B by 2034, the company faces significant headwinds including reliance on a single customer (LabCorp), delisting from Nasdaq and OTCQX, and the uncertain development of replacement pancreatic and Barrett's Esophagus tests.

• · The company's common stock was delisted from Nasdaq and removed from OTCQX trading on August 18, 2025, and now trades on OTCID.
• · The new pancreatic cyst progression test is expected to take 12-24 months to develop, but requires a positive CMS reimbursement determination before launch, with no assurance of success.
• · The Barrett's Esophagus test is unlikely to launch before 2030, if at all.
• · The company's largest customer in 2025 and first half of 2026 for ThyGeNEXT® and ThyraMIR®v2 was LabCorp.
• · Estimated new thyroid cancer cases in 2026: 45,240; estimated deaths: 2,320.

25-09-2026

Mosaic Co has appointed Walt Precourt as Executive Vice President of Operations, effective December 1, 2026. The offer includes a base salary of $710,000, a short-term incentive target of 85%, and a long-term incentive target of $1,725,000, along with a one-time RSU award of $300,000. The filing reflects a routine executive hire with no negative or flat metrics to report.

• · The RSU award vests over three years: 33% on first anniversary, 33% on second, 34% on third.
• · Severance and Change in Control Agreement coverage extends through March 31, 2029.
• · Walt Precourt accepted the offer on September 15, 2026.

25-09-2026

BOXABL Inc. (Nasdaq: BXBL) appointed Timothy Goldsmith, CPA, a former EY audit partner with over 20 years of experience, to its board of directors as Audit Committee Chair, effective September 24, 2026. The appointment follows the recent additions of CFO Larry King and CAO Heather Clayton, as the company builds out its finance and governance infrastructure after going public in July 2026. The filing is a routine governance update with no negative or flat financial metrics reported.

• · Timothy Goldsmith spent nearly 21 years at EY, most recently as an audit partner from 2018 to 2026.
• · Goldsmith oversaw more than 20 complex public and private company audits and led a team of over 30 audit executives.
• · He led audit strategy for companies with revenues ranging from $200 million to over $3 billion.
• · Goldsmith holds a BBA in Accounting and Business Economics from Ohio University and is a CPA licensed in Ohio, Georgia, New Jersey, and Nevada.
• · Dr. Morris A. Davis, who previously chaired the Audit Committee, will remain a member of the committee.
• · BOXABL began trading on Nasdaq under ticker 'BXBL' on July 20, 2026, following its business combination with FG Merger II Corp.
• · The company has raised over $230 million from more than 50,000 investors since its inception in 2017.

25-09-2026

VerifyMe, Inc. held its Annual Meeting of Stockholders on September 24, 2026, with approximately 6,168,364 shares (46.34% of outstanding shares) present or represented by proxy. Stockholders approved the merger with OpenWorld, the advisory compensation of named executive officers, the Fourth Amendment to the 2020 Equity Incentive Plan, and ratified MaloneBailey, LLP as the independent auditor. However, stockholders did not approve the proposal to authorize 500,000,000 shares of new 'blockchain common stock' and related charter amendments, including the name change to 'OpenWorld, Inc.'

• · The merger with OpenWorld was approved, with OpenWorld surviving as a wholly owned subsidiary of VerifyMe.
• · The proposal to authorize 500,000,000 shares of blockchain common stock (par value $0.001 per share) was not approved by stockholders.
• · The company's name change to 'OpenWorld, Inc.' was part of the rejected proposal.
• · The adjournment proposal was approved with 5,703,929 votes for, 454,654 against, and 9,781 abstentions.
• · The company is an emerging growth company and has elected not to use the extended transition period for complying with new financial accounting standards.

25-09-2026

INLIF Ltd terminated its 'At The Market' (ATM) offering sales agreement with AC Sunshine Securities LLC, effective September 19, 2026. During the agreement's term, the company sold approximately 196.2 million Class A ordinary shares (pre-consolidation) and received net proceeds of about $21.15 million, with sales agent costs of $2.14 million. As of the report date, the company has 1,046,390 Class A and 43,908 Class B ordinary shares outstanding.

• · The Sales Agreement was entered into on March 12, 2026.
• · The share consolidation was effected on July 6, 2026 at a 1-for-200 ratio.
• · The termination is effective as of September 19, 2026.
• · The company's shelf registration statement on Form F-3 (File No. 333-292580) was declared effective by the SEC on January 12, 2026.
• · The company's registration statement on Form S-8 (File No. 333-289640) was filed with the SEC on August 15, 2025.

25-09-2026

Black Hawk Acquisition Corp (BKHA) entered into a series of financing agreements with Meteora Select Trading Opportunities Master, LP in connection with its pending business combination with Vesicor Therapeutics. The agreements include a Forward Purchase Agreement for up to 1,350,000 shares, a Non-Redemption Agreement covering up to 2,124,077 shares, a Subscription Agreement, and a Standby Equity Purchase Agreement (SEPA) allowing PubCo to sell up to $200.0 million of common stock over 36 months. While the financing provides up to $200M in potential equity and reduces redemption risk, the terms include significant dilution potential (e.g., 15% original issue discount on prepaid advances) and the SEPA has no mandatory minimum utilization, meaning the full $200M may not materialize.

• · The Business Combination Agreement was originally dated April 26, 2025.
• · The Forward Purchase Agreement allows Meteora to purchase shares in the open market (Recycled Shares) or directly from the Company (Additional Shares).
• · The Non-Redemption Agreement terminates upon certain specified events, with survival provisions.
• · The SEPA permits prepaid advances evidenced by convertible promissory notes with a 12-month maturity and 0% annual interest (18% upon default).
• · The Registration Rights Agreement requires coverage of at least 10,000,000 shares or 300% of the maximum shares issuable upon conversion of outstanding notes.
• · The Company has elected not to use the extended transition period for complying with new financial accounting standards.
• · The securities issued under the Subscription Agreement and SEPA are unregistered and rely on Section 4(a)(2) exemptions.

25-09-2026

Clover Health appointed former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D., M.B.A., M.P.H., to its Board of Directors, effective immediately. The appointments fill two previously disclosed vacancies, bringing the Board to nine directors. Senator Torricelli will serve on the Audit Committee and Dr. Miller on the Clinical Committee, adding depth in public policy, Medicare, clinical practice, and business.

• · Senator Torricelli has served on the board of Clover's insurance subsidiaries since 2022.
• · Dr. Miller is a practicing hospitalist at Johns Hopkins Hospital, an Associate Professor, and a Visiting Fellow at the Hoover Institution.
• · Dr. Miller serves as Vice Chairman of the Board of Trustees for the North Carolina State Health Plan and as a Commissioner on MedPAC.
• · Senator Torricelli previously served as executive vice president and chief operating officer of Aveta, Inc.

25-09-2026

Elroy Air, a developer of autonomous heavy-cargo drones, announced an upsizing of its PIPE investments to $175 million in connection with its proposed business combination with Inflection Point Acquisition Corp. VII (IPAC). Lockheed Martin Ventures and existing investors participated, with $75 million already funded prior to closing. The company also highlighted recent milestones including a $46 million U.S. Army contract, expanded early delivery reservations from Bristow Group (15 total), and the first autonomous flights under the FAA's eIPP program.

• · Elroy Air has been awarded a multi-year contract worth up to $46 million with the U.S. Army, building on previous contracts from the past two years.
• · Elroy Air completed the first autonomous and uncrewed flights authorized under the FAA's eIPP program, in partnership with LIFTOFF Louisiana and Bristow Group.
• · Bristow Group expanded its early delivery reservations for Chaparral by 10 additional positions, for a total of 15, and has a pre-order agreement for up to 100 Chaparral drones.
• · Kratos Defense & Security Solutions is the exclusive U.S. manufacturer of Chaparral, with first production aircraft planned for late 2026 at its Sacramento, California facility.
• · The Chaparral drone has a cargo capacity of 500+ pounds, a range of up to 450 miles, and a hybrid-electric powertrain requiring no charging infrastructure.

25-09-2026

Jaguar Health, Inc. entered into an Exchange Agreement with Streeterville Capital, LLC on September 23, 2026, to partition a portion of an existing Secured Promissory Note (originally issued January 19, 2021) and exchange it for shares of common stock. The exchange is intended to comply with Section 3(a)(9) of the Securities Act, with the shares to be issued free of restrictive legends. No new cash consideration is involved; the transaction reduces the outstanding balance of the original note by the amount of the partitioned note.

• · The Exchange Shares are to be delivered via DWAC to Lender's designated brokerage account on or before September 24, 2026.
• · The holding period for Rule 144 purposes includes the Lender's holding period of the Original Note from November 12, 2025.
• · Lender represents it will not beneficially own more than 9.99% of outstanding common stock after the exchange.
• · No Event of Default has occurred under the Original Note, and any prior defaults are not waived.
• · The exchange is structured as a substitution and exchange, not a novation or satisfaction of the Partitioned Note.

25-09-2026

Chief Financial Officer Pan Ming-Feng was awarded 1,629 Restricted Stock Units.

• · Chief Financial Officer Pan Ming-Feng was awarded 1,629 Restricted Stock Units

25-09-2026

Director Wu Maggie Wei was awarded 32,000 Ordinary Shares. Wu Maggie Wei holds 3,686,160 shares after the transaction.

• · Director Wu Maggie Wei was awarded 32,000 Ordinary Shares

25-09-2026

CEO and Chairman Zhu Muchun bought 1,625,000 Class B Ordinary Shares at $0.40 (~$650K). Zhu Muchun holds 1,831,598.04 shares after the transaction.

• · CEO and Chairman Zhu Muchun bought 1,625,000 Class B Ordinary Shares at $0.40 (~$650K)

25-09-2026

VP and Controller POOLE LISA M. sold 200 Common Stock at $348.01 (~$69.6K). POOLE LISA M. holds 6,134 shares after the transaction.

• · VP and Controller POOLE LISA M. sold 200 Common Stock at $348.01 (~$69.6K)

25-09-2026

Director HO LAWRENCE YAU LUNG bought 1,043,600 Class A Ordinary shares at $0.20 (~$206K). HO LAWRENCE YAU LUNG holds 463,391,904 shares after the transaction.

• · Director HO LAWRENCE YAU LUNG bought 1,043,600 Class A Ordinary shares at $0.20 (~$206K)

25-09-2026

Lloyds Banking Group plc completed its £1.75 billion share buyback programme, which was announced on 30 January 2026 and managed by Goldman Sachs International. Between 30 January 2026 and 24 September 2026, the company repurchased 1,712,662,647 ordinary shares for an aggregate consideration of £1.75 billion. The filing does not provide any negative or flat performance metrics, as it solely reports the completion of the buyback.

• · The buyback programme was announced on 30 January 2026 and completed on 24 September 2026.
• · The programme was managed by Goldman Sachs International.
• · The last purchase of ordinary shares occurred on 24 September 2026.

25-09-2026

Valor Energy Inc (formerly Senmiao Technology Ltd) filed an S-3 registration statement with the SEC on September 24, 2026, to register securities for a potential future offering. The filing details the company's corporate structure, including its PRC subsidiary Hunan Ruixi, and highlights significant regulatory risks related to PRC foreign exchange controls and dividend distribution restrictions. Notably, the company deconsolidated its former VIE Jinkailong as of March 31, 2022, and as of March 31, 2026, Jinkailong's paid-in capital was zero. No dividends have ever been paid to any investors.

• · The company changed its name from Senmiao Technology Ltd to Valor Energy Inc on July 3, 2017.
• · As of March 31, 2026, Jinkailong's paid-in capital was zero.
• · No dividends or distributions have ever been paid to any investors by Valor's subsidiaries or equity investee.
• · The PRC subsidiary Hunan Ruixi is restricted from transferring net assets to Valor due to PRC laws, including a requirement to allocate 10% of after-tax profit to statutory reserve until the reserve reaches 50% of registered capital.
• · All online ride-hailing drivers and vehicles under management have obtained the required licenses and certificates as of March 31, 2026.

25-09-2026

CCO and GC Wang Yanjun sold 816 Class A ordinary shares at $102.77 (~$83.9K). 6 transactions reported in total. Wang Yanjun holds 93,980 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · CCO and GC Wang Yanjun sold 186 Class A ordinary shares at $101.95 (~$19K)
• · CCO and GC Wang Yanjun sold 816 Class A ordinary shares at $102.77 (~$83.9K)
• · CCO and GC Wang Yanjun sold 198 Class A ordinary shares at $103.46 (~$20.5K)
• · CCO and GC Wang Yanjun sold 584 Class A ordinary shares at $100.86 (~$58.9K)
• · CCO and GC Wang Yanjun sold 574 Class A ordinary shares at $101.75 (~$58.4K)
• · CCO and GC Wang Yanjun sold 42 Class A ordinary shares at $102.31 (~$4.3K)